Microplastics turned up in every human bile sample tested and pushed duct cells toward mitochondrial dysfunction and senescence, with melatonin showing protective effects.

A new metabolic mechanism describes how tumors disable “gatekeeper” cells to prevent immune response to cancer.

Researchers suggest their approach has the potential to transform early disease detection and health monitoring across diverse clinical settings.

The integrated approach is designed to adapt to the evolving needs of new therapeutic modalities, delivering both speed and performance.

Directly transferring healthy mitochondria or cytoplasmic components into target cells is particularly relevant for regenerative medicine.

Eli Lilly has won FDA approval for its oral obesity drug Foundayo™ (orforglipron), but the stock bounce was short lived as ...

Microgels mimic the mechanical properties of natural platelets to maximize the ability of the B peptides to create fibrin ...

These pillars are composed of polyacrylamide hydrogel, a material whose stiffness can be adjusted to match the ~5 kPa ...

Eric Green, MD, PhD, Chief Medical Officer of Illumina, was awarded the Distinguished Service Award by board members of The Genome Partnership—the nonprofit organization that has organized the ...

Combination therapy led to complete remission in more than 50% of mice with different tumor types, many of which were resistant to ICB therapy alone.

The data shows when the protein is removed from neurons or has its signaling activity blocked with drugs, axonal fibers grew more effectively.

FDA approval of the first organoid-supported IND application augurs a future in which new approach methodologies supplant animal testing.